Skip to content


Amondys (casimersen) is an oligonucleotide pharmaceutical. Casimersen was first approved as Amondys on 2021-02-25. It is used to treat duchenne muscular dystrophy in the USA. Amondys 45's patents are valid until 2030-11-12 (FDA).
Trade Name Amondys
Common Name Casimersen
Indication duchenne muscular dystrophy
Drug Class Antisense oligonucleotides
Get full access now